Metabolism of vitamin D3 in human osteoblasts:: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3

被引:191
作者
Atkins, Gerald J.
Anderson, Paul H.
Findlay, David M.
Welldon, Katie J.
Vincent, Cristina
Zannettino, Andrew C. W.
O'Loughlin, Peter D.
Morris, Howard A.
机构
[1] Univ Adelaide, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia
[3] Hanson Inst, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
vitamin D; 25-hydroxyvitamin D-3; CYP24; CYP27B1; osteoblasts;
D O I
10.1016/j.bone.2007.02.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating 1 alpha,25-dihydroxyvitamin D-3 (1,25D) derives from renal conversion of 25-hydroxyvitamin D-3 (25D), by the 25D 1 alpha-hydroxylase (CYP27B1). Blood 25D levels, but not 1,25D levels, are the best indicator of vitamin D status and predict fracture risk in the elderly. We examined the extent to which osteoblasts can metabolize 25D. Well-characterized human primary osteoblasts and osteosarcoma (OS) cell lines were examined for the expression and regulation of genes associated with vitamin D metabolism, using real-time PCR. Primary osteoblasts and OS cell lines were found to express CYP27B1 mRNA and secreted detectable 1,25D in response to 25D. Of the OS cell lines tested, HOS expressed the most CYP27B1 mRNA and secreted the highest levels of 1,25D. All osteoblastic cells examined up-regulated expression of the catabolic regulator of 1,25D, the 25-hydroxyvitamin D-24-hydroxylase (CYP24), when incubated with either 1,25D or 25D. Exposure to physiological levels of 25D resulted in up-regulated transcription of the 1,25D responsive genes, osteocalcin (OCN), osteopontin (OPN) and RANKL. Specific knockdown of CYP27B1 in HOS cells using siRNA resulted in up to 80% reduction in both 1,25D secretion and the transcription of OCN and CYP24, strongly implying that the 25D effect in osteoblasts is preceded by conversion to 1,25D. Incubation with 25D, like 1,251), inhibited primary osteoblast proliferation and promoted in vitro mineralization. Finally, we detected expression by osteoblasts of receptors for vitamin D binding protein (DBP), cubilin and megalin, suggesting that osteoblasts are able to internalize DBP-25D complexes in vivo. Together, our results suggest that autocrine, and perhaps paracrine, pathways of vitamin D-3 metabolism may regulate key osteoblast functions independently of circulating, kidney derived 1,25D. Our results are therefore consistent with the reported benefits of maintaining a healthy vitamin D status in the elderly to reduce the risk of fractures. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1517 / 1528
页数:12
相关论文
共 50 条
  • [31] Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro
    Deb, Subrata
    Chin, Mei Yieng
    Adomat, Hans
    Guns, Emma S. Tomlinson
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 : 50 - 58
  • [32] Effects of 1, 25-Dihydroxyvitamin D3 on Experimental Autoimmune Myocarditis in Mice
    Hu, Fen
    Yan, Lianhua
    Lu, Shuai
    Ma, Wenhan
    Wang, Ya
    Wei, Yuzhen
    Yan, Xiaofei
    Zhao, Xin
    Chen, Zhijian
    Wang, Zhaohui
    Cheng, Bo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (06) : 2219 - 2229
  • [33] Enhanced Radiosensitivity in 1,25-dihydroxyvitamin D3 Deficient Mice
    Zhang, Zeng-Li
    Ding, Xiao-Fei
    Tong, Jian
    Li, Bing-Yan
    JOURNAL OF RADIATION RESEARCH, 2011, 52 (02) : 215 - 219
  • [34] Sustained osteoblast nuclear receptor binding of converted 1α,25-dihydroxyvitamin D3 after administration of 3H-1α-hydroxyvitamin D3:: A combined receptor autoradiography and radioassay time course study with comparison to 3H-1α,25-dihydroxyvitamin D3
    Koike, N
    Ichikawa, F
    Nishii, Y
    Stumpf, WE
    CALCIFIED TISSUE INTERNATIONAL, 1998, 63 (05) : 391 - 395
  • [35] Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3
    Manuel Quesada-Gomez, Jose
    Santiago-Mora, Raquel
    Navarro-Valverde, Cristina
    Dorado, Gabriel
    Casado-Diaz, Antonio
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 : 214 - 218
  • [36] A Kinetic Overview of the Receptors Involved in 1,25-Dihydroxyvitamin D3 and 24,25-Dihydroxyvitamin D3 Signaling: A Systems Biology Approach
    Holmen, Jonathan
    Jansson, Andreas
    Larsson, Dennis
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2009, 19 (03): : 181 - 196
  • [37] Synthesis of 1α25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1α25,-dihydroxyvitamin D3 antagonist
    Kato, Y
    Nakano, Y
    Sano, H
    Tanatani, A
    Kobayashi, H
    Shimazawa, R
    Koshino, H
    Hashimoto, Y
    Nagasawa, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) : 2579 - 2583
  • [38] Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines
    Thompson, Lindsey
    Wang, Shanshan
    Tawfik, Ossama
    Templeton, Kimberly
    Tancabelic, Jakica
    Pinson, David
    Anderson, H. Clarke
    Keighley, John
    Garimella, Rama
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (05) : 831 - 844
  • [39] Novel Gemini analogs of 1α,25-dihydroxyvitamin D3 with enhanced transcriptional activity
    Weyts, FA
    Dhawan, P
    Zhang, XY
    Bishop, JE
    Uskokovic, MR
    Ji, Y
    Studzinski, GP
    Norman, AW
    Christakos, S
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (07) : 1327 - 1336
  • [40] 1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice
    Lazzara, Francesca
    Amato, Rosario
    Platania, Chiara Bianca Maria
    Conti, Federica
    Chou, Tsung-Han
    Porciatti, Vittorio
    Drago, Filippo
    Bucolo, Claudio
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)